01 1Jubilant HollisterStier LLC
02 1Sigma-Aldrich Corporation
03 2Sterling Pharma Solutions Limited
01 1TETRAKIS(2-METHOXYISOBUTYLISOCYANIDE)COPPER(I) TETRAFLUOROBORATE
02 1Tetrakis(2-methoxy isobutyl isonitrile) copper(I) tetrafluoroborate
03 1Tetrakis(2-methoxyisobutylisocyanide)Copper(I) tetrafluoroborate
04 1tetrakis(2-methoxyisobutylisocyanide)copper(i) tetrafluoroborate
01 2U.S.A
02 2United Kingdom
TETRAKIS(2-METHOXYISOBUTYLISOCYANIDE)COPPER(I) TETRAFLUOROBORATE
NDC Package Code : 65044-0020
Start Marketing Date : 2016-10-19
End Marketing Date : 2025-12-31
Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION (1mg/mL)
Marketing Category : DRUG FOR FURTHER PROCESSING
TETRAKIS(2-METHOXYISOBUTYLISOCYANIDE)COPPER(I) TETRAFLUOROBORATE
NDC Package Code : 58272-200
Start Marketing Date : 2008-05-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
TETRAKIS(2-METHOXYISOBUTYLISOCYANIDE)COPPER(I) TETRAFLUOROBORATE
NDC Package Code : 50384-0700
Start Marketing Date : 2009-07-10
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (400g/400g)
Marketing Category : BULK INGREDIENT
TETRAKIS(2-METHOXYISOBUTYLISOCYANIDE)COPPER(I) TETRAFLUOROBORATE
NDC Package Code : 50384-2804
Start Marketing Date : 2017-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
A Tetrakis(2-Methoxyisobutylisocyanide)Copper(I) Tetrafluoroborate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Tetrakis(2-Methoxyisobutylisocyanide)Copper(I) Tetrafluoroborate, including repackagers and relabelers. The FDA regulates Tetrakis(2-Methoxyisobutylisocyanide)Copper(I) Tetrafluoroborate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Tetrakis(2-Methoxyisobutylisocyanide)Copper(I) Tetrafluoroborate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Tetrakis(2-Methoxyisobutylisocyanide)Copper(I) Tetrafluoroborate supplier is an individual or a company that provides Tetrakis(2-Methoxyisobutylisocyanide)Copper(I) Tetrafluoroborate active pharmaceutical ingredient (API) or Tetrakis(2-Methoxyisobutylisocyanide)Copper(I) Tetrafluoroborate finished formulations upon request. The Tetrakis(2-Methoxyisobutylisocyanide)Copper(I) Tetrafluoroborate suppliers may include Tetrakis(2-Methoxyisobutylisocyanide)Copper(I) Tetrafluoroborate API manufacturers, exporters, distributors and traders.
click here to find a list of Tetrakis(2-Methoxyisobutylisocyanide)Copper(I) Tetrafluoroborate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Tetrakis(2-Methoxyisobutylisocyanide)Copper(I) Tetrafluoroborate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Tetrakis(2-Methoxyisobutylisocyanide)Copper(I) Tetrafluoroborate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Tetrakis(2-Methoxyisobutylisocyanide)Copper(I) Tetrafluoroborate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Tetrakis(2-Methoxyisobutylisocyanide)Copper(I) Tetrafluoroborate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Tetrakis(2-Methoxyisobutylisocyanide)Copper(I) Tetrafluoroborate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Tetrakis(2-Methoxyisobutylisocyanide)Copper(I) Tetrafluoroborate suppliers with NDC on PharmaCompass.
We have 3 companies offering Tetrakis(2-Methoxyisobutylisocyanide)Copper(I) Tetrafluoroborate
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?